The incidence of hepatitis B infection in Australia: an epidemiological review.
Hepatitis B virus (HBV) infection in Australia remains a significant problem despite the availability of an inexpensive vaccine. National information about incidence, prevalence, morbidity and the extent of vaccine coverage is incomplete; improved surveillance would allow for better targeting and evaluation of prevention activities. Our estimates indicate that 75%-90% of cases of vertical transmission of HBV are preventable through vaccination of newborns whose mothers are carriers.
Kaldor
J M
JM
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW.
Plant
A J
AJ
Thompson
S C
SC
Longbottom
H
H
Rowbottom
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D001315:Australia / Q000453:epidemiology; D002353:Carrier State / Q000821:virology; D002648:Child; D002675:Child, Preschool; D018562:Disease Transmission, Infectious; D005260:Female; D006509:Hepatitis B / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D017325:Hepatitis B Vaccines; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D014611:Vaccination; D000095283:Australian Aboriginal and Torres Strait Islander Peoples
D017325:Hepatitis B Vaccines